Wie hoch ist der Preis für LifeMD, Inc. (LFMDP)

Preis für LifeMD, Inc. (LFMDP) ist $23.31

Wie hoch ist die Marktkapitalisierung für LifeMD, Inc. (LFMDP)

Marktkapitalisierung für LifeMD, Inc. (LFMDP) ist $1.05B

LifeMD, Inc. (LFMDP) KBV

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Jahr	P/B-Verhältnis	ändert
2026 (TTM)	8.04	-121.63%
2024	-37.17	-146.36%
2023	80.18	-1,011.32%
2022	-8.80	-326.03%
2021	3.89	-94.35%
2020	68.85	-1,245.64%
2019	-6.01	-187.21%
2018	6.89	-59.35%
2017	16.95	-165.71%
2016	-25.80	-169.84%
2015	36.94	-269.68%
2014	-21.77	-155.73%
2013	39.07	19.77%
2012	32.62	-222.81%
2011	-26.56	0.00%

Jahr

P/B-Verhältnis

ändert

2026 (TTM)

8.04

-121.63%

2024

-37.17

-146.36%

2023

80.18

-1,011.32%

2022

-8.80

-326.03%

2021

3.89

-94.35%

2020

68.85

-1,245.64%

2019

-6.01

-187.21%

2018

6.89

-59.35%

2017

16.95

-165.71%

2016

-25.80

-169.84%

2015

36.94

-269.68%

2014

-21.77

-155.73%

2013

39.07

19.77%

2012

32.62

-222.81%

2011

-26.56

0.00%

Unternehmen	P/B-Verhältnis	P/B-Verhältnis-Differenz	Land
Alibaba Health Information Technology Limited 0241.HK	4.0603	-49.49%	HK
Raia Drogasil S.A. RADL3.SA	5.6268	-30.01%	BR
MatsukiyoCocokara & Co. 3088.T	1.8509	-76.98%	JP
Yifeng Pharmacy Chain Co., Ltd. 603939.SS	2.7212	-66.15%	CN
Sugi Holdings Co.,Ltd. 7649.T	2.192	-72.73%	JP

Unternehmen

P/B-Verhältnis

P/B-Verhältnis-Differenz

Land